Back to GetFilings.com




 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 10-Q
(Mark One)
X     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
   OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2004
or
___ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
   SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number 1-11316

OMEGA HEALTHCARE
INVESTORS, INC.
(Exact name of Registrant as specified in its charter)

   Maryland                   38-3041398
(State of Incorporation)               (I.R.S. Employer Identification No.)

9690 Deereco Road, Suite 100, Timonium, MD 21093
(Address of principal executive offices)

(410) 427-1700
(Telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

           Yes X                No ___

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
           Yes X                No ___

Indicate the number of shares outstanding of each of the issuer's classes of common stock as of  August 3, 2004.

Common Stock, $.10 par value           46,572.987
       (Class)                    (Number of shares)


 
     
 
 

OMEGA HEALTHCARE INVESTORS, INC.
FORM 10-Q
June 30, 2004

TABLE OF CONTENTS
 
 
Page No.
PART I
Financial Information
 
 
 
 
Item 1.
Financial Statements:
 
 
Consolidated Balance Sheets
 
 
June 30, 2004 (unaudited) and December 31, 2003
2
 
 
 
 
Consolidated Statements of Operations (unaudited)
 
 
Three and six months ended June 30, 2004 and 2003
3
 
 
 
 
Consolidated Statements of Cash Flows (unaudited)
 
 
Six months ended June 30, 2004 and 2003
4
 
 
 
 
Notes to Consolidated Financial Statements
 
 
June 30, 2004 (unaudited)
5
 
 
 
Item 2.
Management’s Discussion and Analysis of Financial Condition
 
 
and Results of Operations
17
 
 
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
35
 
 
 
Item 4.
Controls and Procedures
35
 
 
 
PART II
Other Information
 
 
 
 
Item 1.
Legal Proceedings
36
 
 
 
Item 2.
Changes in Securities, Use of Proceeds and Issuer Purchase of Equity Securities   
36
 
 
 
Item 4.
Submission of Matters to a Vote of Security Holders
37
 
 
 
Item 6.
Exhibits and Reports on Form 8-K
38
 
 
 




     

PART 1 – FINANCIAL INFORMATION

Item 1.   Financial Statements
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
 
  
June 30,
December 31,
 
  
2004
2003
   
 
  
(Unaudited)
(See note)
ASSETS
  
 
 
Real estate properties
    
 
    
 
  
Land and buildings at cost
  
$
727,998
  
$
692,454
  
Less accumulated depreciation
    
(144,569
)
  
(134,477
)
   
 
 
   Real estate properties – net
    
583,429
    
557,977
  
Mortgage notes receivable – net
    
114,233
    
119,815
  
   
 
 
 
    
697,662
    
677,792
  
Other investments – net
    
36,392
    
29,787
  
   
 
 
Total investments
    
734,054
    
707,579
  
 
    
 
    
 
  
Cash and cash equivalents
    
2,662
    
3,094
  
Accounts receivable – net
    
3,063
    
1,893
  
Interest rate cap
    
—
    
5,537
  
Other assets
    
11,827
    
8,562
  
Operating assets for owned properties
    
649
    
2,289
  
   
 
 
Total assets
  
$
752,255
  
$
728,954
  
   
 
 
 
    
 
    
 
  
LIABILITIES AND STOCKHOLDERS’ EQUITY
    
 
    
 
  
Revolving lines of credit
  
$
35,000
  
$
177,074
  
Unsecured borrowings
    
300,000
    
100,000
  
Other long–term borrowings
    
3,520
    
3,520
  
Accrued expenses and other liabilities
    
20,363
    
8,194
  
Operating liabilities for owned properties
    
4,538
    
3,931
  
   
 
 
Total liabilities
    
363,421
    
292,719
  
   
 
 
 
    
 
    
 
  
Stockholders’ equity:
    
 
    
 
  
Preferred stock
    
168,488
    
212,342
  
Common stock and additional paid-in-capital
    
549,059
    
485,196
  
Cumulative net earnings
    
169,915
    
174,275
  
Cumulative dividends paid
    
(455,841
)
  
(431,123
)
Cumulative dividends – redemption
    
(41,054
)
  
—
  
Accumulated other comprehensive loss
    
(1,733
)
  
(4,455
)
   
 
 
Total stockholders’ equity
    
388,834
    
436,235
  
   
 
 
Total liabilities and stockholders’ equity
  
$
752,255
  
$
728,954
  
   
 
 

Note – The balance sheet at December 31, 2003 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.
See notes to consolidated financial statements.
     

 
     
 
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)

 
  
 
 
 
 
 
  
Three Months Ended
Six Months Ended
 
  
June 30,
June 30,
   
 
  
2004
2003
2004
2003
   
 
 
 
 
Revenues
    
 
    
 
    
 
    
 
  
Rental income    
  
$
18,170
 
$
15,898
 
$
35,293
 
$
32,317
  
Mortgage interest income    
    
3,336
   
3,489
   
6,703
   
7,881
 
Other investment income – net    
    
548
   
756
   
1,189
   
1,746
 
Miscellaneous    
    
291
   
302
   
421
   
569
 
Nursing home revenues of owned and operated assets    
    
-
    
1,044
   
-
    
2,379
 
   
 
 
 
 
Total operating revenues
    
22,345
   
21,489
   
43,606
   
44,892
 
Expenses
    
 
    
 
    
 
    
 
  
Depreciation and amortization    
    
5,385
   
5,277
   
10,608
   
10,483
 
General and administrative    
    
1,401
   
1,622
   
2,914
   
3,251
 
Legal    
   
382
    
784
    
872
    
1,342
  
Nursing home expenses of owned and operated assets    
    
-
    
1,035
   
-
    
3,509
 
   
 
 
 
 
Total operating expenses
    
7,168
    
8,718
    
14,394
    
18,585
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
Income before other income and expense    
    
15,177
    
12,771
    
29,212
    
26,307
  
Other income (expense):
    
 
    
 
    
 
    
 
  
Interest and other investment income    
    
77
    
88
   
96
   
142
 
Interest    
    
(5,753
)
  
(4,315
)
  
(10,446
)
  
(8,735
)
Interest – amortization of deferred financing costs    
    
(427
)
  
(482
)
  
(881
)
  
(1,174
)
Interest – refinancing costs    
    
-
    
(2,586
)
  
(19,106
)
  
(2,586
)
Owned and operated professional liability claims    
    
(3,000
)
  
-
    
(3,000
)
  
-
  
Litigation settlements    
    
-
    
-
    
-
    
2,187
  
Provision for impairment    
    
-
    
-
    
-
    
(4,618
)
Adjustment of derivative to fair value    
    
-
    
-
    
256
    
-
 
   
 
 
 
 
Total other (expense) income    
    
(9,103
)
  
(7,295
)
  
(33,081
)
  
(14,784
)
 
    
 
    
 
    
 
    
 
  
Income (loss) before gain on assets sold
    
6,074
    
5,476
    
(3,869
)
  
11,523
  
Gain from assets sold – net     
    
-
    
1,338
    
-
    
1,338
 
   
 
 
 
 
Income (loss) from continuing operations    
    
6,074
    
6,814
    
(3,869
)
  
12,861
  
(Loss) gain from discontinued operations    
    
(137
)
  
15
    
(491
)
  
(47
)
   
 
 
 
 
Net income (loss)    
    
5,937
    
6,829
    
(4,360
)
  
12,814
  
Preferred stock dividends    
    
(4,002
)
  
(5,029
)
  
(8,689
)
  
(10,058
)
Preferred stock conversion and redemption charges    
    
(2,311
)
  
-
    
(41,054
)
  
-
  
   
 
 
 
 
Net (loss) income available to common    
  
$
(376
)
$
1,800
  
$
(54,103
)
$
2,756
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
(Loss) income per common share:
    
 
    
 
    
 
    
 
  
Basic:
    
 
    
 
    
 
    
 
  
(Loss) income from continuing operations    
  
$
(0.01
)
$
0.05
  
$
(1.22
)
$
0.08
  
   
 
 
 
 
Net (loss) income    
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 
Diluted:
    
 
    
 
    
 
    
 
  
(Loss) income from continuing operations    
  
$
(0.01
)
$
0.05
  
$
(1.22
)
$
0.07
  
   
 
 
 
 
Net (loss) income    
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
Dividends declared and paid per common share    
  
$
0.18
  
$
-
  
$
0.35
 
  $
          -
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
Weighted-average shares outstanding, basic    
    
46,365
    
37,153
    
43,912
    
37,149
  
   
 
 
 
 
Weighted-average shares outstanding, diluted     
    
46,365
    
37,625
    
43,912
    
37,415
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
Components of other comprehensive income:
    
 
    
 
    
 
    
 
  
Net income (loss)    
  
$
5,937
  
$
6,829
  
$
(4,360
)
$
12,814
 
Unrealized (loss) gain on investments and hedging contracts    
    
(1,733
)
  
(2,529
)
  
2,722
    
(3,152
)
   
 
 
 
 
Total comprehensive income (loss)    
  
$
4,204
  
$
4,300
  
$
(1,638
)
$
9,662
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
See notes to consolidated financial statements.

 
     
 
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited (in thousands)
 
  
Six Months Ended
June 30,
   
 
  
2004
2003
   
Operating activities
  
 
 
Net (loss) income
  
$
(4,360
)
$
12,814
  
Adjustment to reconcile net income to cash provided by operating activities:
    
 
    
 
  
   Depreciation and amortization
    
10,608
    
10,483
  
   Provisions for impairment
    
—
    
4,618
  
   Refinancing costs
    
19,106
    
2,586
  
   Amortization for deferred finance costs
    
780
    
1,167
  
   Loss (gain) on assets sold – net
    
440
    
(1,338
)
   Amortization of derivatives
    
101
    
7
  
   Adjustment of derivatives to fair value
    
(256
)
  
—
  
   Other
    
(23
)
  
297
  
Net change in accounts receivable
    
(1,170
)
  
191
  
Net change in other assets
    
(65
)
  
(444
)
Net change in operating assets and liabilities
    
(857
)
  
1,241
  
   
 
 
Net cash provided by operating activities
    
24,304
    
31,622
  
   
 
 
 
    
 
    
 
  
Cash flows from investing activities
    
 
    
 
  
Acquisition of real estate
   
(34,114
)
  
—
  
Proceeds from sale of stock
   
480
    
—
  
Proceeds from sale of real estate investments
   
135
    
189
  
Capital improvements and funding of other investments
    
(2,049
)
  
(1,307
)
Proceeds from other investments and assets held for sale – net
    
2,531
    
12,263
  
Investments in other investments – net
    
(2,776
)
  
—
  
Collection of mortgage principal
    
5,582
    
2,616
  
   
 
 
Net cash (used in) provided by investing activities
    
(30,211
)
  
13,761
  
   
 
 
 
    
 
    
 
  
Cash flows from financing activities
    
 
    
 
  
Proceeds from new credit facility borrowings
   
40,000
    
—
  
Payments of new credit facility borrowings
    
(5,000
)
  
—
  
Proceeds from terminated credit facility borrowings
   
13,700
    
187,122
  
Payments of terminated credit facility borrowings
    
(190,774
)
  
(177,000
)
Terminated credit facility exit fee
   
(6,378
)
  
—
  
Proceeds from (payments of) long-term borrowings
    
200,000
    
(17,827
)
Proceeds from sale of interest rate cap
    
3,460
    
—
  
Receipts from Dividend Reinvestment Plan
    
81
    
3
  
Receipts from exercised options
    
2,349
    
—
  
Dividends paid
    
(20,077
)
  
—
  
Redemption of preferred stock
    
(57,500
)
  
—
  
Proceeds from preferred stock offering
    
13,646
    
—
  
Proceeds from common stock offering
    
22,368
    
—
  
Deferred financing costs paid
    
(10,400
)
  
(7,204
)
   
 
 
Net cash provided by (used in) financing activities
    
5,475
    
(14,906
)
   
 
 
 
    
 
    
 
  
(Decrease) increase in cash and cash equivalents
    
(432
)
  
30,477
  
Cash and cash equivalents at beginning of period
    
3,094
    
14,340
  
   
 
 
Cash and cash equivalents at end of period
  
$
2,662
  
$
44,817
  
   
 
 
Interest paid during the period
  
$
7,397
  
$
8,798
  
   
 
 
See notes to consolidated financial statements.

     

 
     
 
OMEGA HEALTHCARE INVESTORS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
June 30, 2004

NOTE 1 – BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements for Omega Healthcare Investors, Inc. (“Omega” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Certain reclassifications have been made to the 2003 financial statements for consistency with the presentation adopted for 2004. Such reclassifications have no effect on previously reported earnings or equity.

In December 2003, the Financial Accounting Standards Board (“FASB”) issued Financial Interpretation Number (“FIN”) 46 (revised December 2003), Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51 (“FIN 46R”). FIN 46R addresses consolidation by business enterprises of variable interest entities. As of June 30, 2004, we did not have any entities that met the definition of a variable interest entity under FIN 46R; therefore, the provisions of FIN 46R did not have an impact on our consolidated results of operations or financial position.

Operating results for the three- and six-month periods ended June 30, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the financial statements and footnotes included in our annual report on Form 10-K for the year ended December 31, 2003.

We have one primary reportable segment consisting of investments in real estate. Our primary business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities located in the United States. Our core portfolio consists of long-term lease and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property related expenses. Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor. Substantially all depreciation expenses reflected in the consolidated statement of operations relate to the ownership of our investment in real estate.


NOTE 2 – PROPERTIES

In the ordinary course of our business activities, we periodically evaluate investment opportunities and extend credit to customers. We also regularly engage in lease and loan extensions and modifications. Additionally, we actively monitor and manage our investment portfolio with the objectives of improving credit quality and increasing returns. In connection with portfolio management, we engage in various collection and foreclosure activities.

If we acquire real estate pursuant to a foreclosure, lease termination or bankruptcy proceeding and do not immediately re-lease or sell the properties to new operators, the assets will be included on the balance sheet as “foreclosed real estate properties,” and the value of such assets is reported at the lower of cost or estimated fair value.


The table below summarizes our number of properties and investment by category for the quarter ended June 30, 2004:

 
  
 
 
 
Total
 
  
Purchase /
Mortgages
Closed
Healthcare
Facility Count
  
Leaseback
Receivable
Facilities
Facilities
  
 
 
 
 
Balance at March 31, 2004
    
154
    
51
    
4
    
209
  
Properties closed
    
-
    
-
    
-
    
-
  
Properties sold/mortgages paid
    
-
    
(5
)
  
(1
)
  
(6
)
Transition leasehold interest
    
-
    
-
    
-
    
-
  
Properties acquired
    
5
    
-
    
-
    
5
  
Properties transferred to purchase/leaseback
    
-
    
-
    
-
    
-
  
   
 
 
 
 
Balance at June 30, 2004
    
159
    
46
    
3
    
208
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
Investment ($000’s)
    
 
    
 
    
 
    
 
  
                          
Balance at March 31, 2004
  
$
688,277
  
$
119,225
  
$
4,088
  
$
811,590
  
Properties closed
    
-
    
-
    
-
    
-
  
Properties sold/mortgages paid
    
-
    
(4,470
)
  
(309
)
  
(4,779
)
Transition leasehold interest
    
-
    
-
    
-
    
-
  
Properties acquired
    
34,600
    
-
    
-
    
34,600
  
Properties transferred to purchase/leaseback
    
-
    
-
    
-
    
-
  
Impairment on properties
    
-
    
-
    
-
    
-
  
Capex and other
    
1,342
    
(522
)
  
-
    
820
  
   
 
 
 
 
Balance at June 30, 2004
  
$
724,219
  
$
114,233
  
$
3,779
  
$
842,231
  
   
 
 
 
 

Purchase/Leasebacks

Set forth below is a summary of the lease transactions which occurred in the first six months of 2004.

Haven Healthcare

·On April 1, 2004, we purchased three skilled nursing facilities (“SNFs”), representing 399 beds, for a total investment of $26.0 million. Two of these facilities are located in Vermont and the third is located in Connecticut. The facilities were combined into an existing Master Lease with Haven Healthcare (“Haven”). Rent under the Master Lease was increased by approximately $2.7 million for the first lease year commencing on April 1, 2004, with annual increases thereafter. The term of the Master Lease had been increased to ten years on January 1, 2004 and runs through December 31, 2013, followed by two ten-year renewal options. We received a security deposit equivalent to three months of incremental rent.

Senior Management

·On May 1, 2004, we purchased two SNFs, representing 477 beds, for a total investment of $9.4 million. The purchase price includes funds for capital expenditures, additional bed licenses and transaction costs. Both facilities are located in Texas and were combined into an existing Master Lease with Senior Management. Rent under the Master Lease was increased by approximately $1.0 million for the first lease year commencing on May 1, 2004, with annual increases thereafter. The term of the Master Lease has been increased to ten years, and is followed by two ten-year renewal options. During the first lease year, Senior Management will fund a security deposit equivalent of approximately four months of incremental rent.

Sun Healthcare Group, Inc.

·On March 1, 2004, we re-leased two SNFs formerly leased by Sun Healthcare Group, Inc. (“Sun”) located in California and representing 117 beds, to a new operator under a Master Lease, which has a ten-year term. The commencement date of the first re-lease was March 1, 2004, with an initial annual lease rate of approximately $0.12 million. The second facility continues to be operated by Sun as a result of licensing issues. We are currently seeking alternative operators to re-lease or potentially purchase this facility.

·On March 1, 2004, we entered into an agreement with Sun regarding 51 properties that are leased to various affiliates of Sun. Under the terms of a master lease agreement, Sun will continue to operate and occupy 23 long-term care facilities, five behavioral properties and two hospital properties through December 31, 2013. One property, located in Washington and formerly operated by a Sun affiliate, has already been closed and the lease relating to that property has been terminated. With respect to the remaining 20 facilities, 17 have already been transitioned to new operators and three are in the process of being transferred to new operators.

·Effective January 1, 2004, we re-leased five SNFs to an existing operator under a new Master Lease, which has a five-year term and an initial annual lease rate of $0.75 million. These SNFs consist of four former Sun SNFs, three located in Illinois and one located in Indiana, representing an aggregate of 449 beds. The fifth SNF in the transaction, located in Illinois and representing 128 beds, was the last remaining owned and operated facility in our portfolio.

Claremont Healthcare Holdings, Inc.

·Effective March 8, 2004, we re-leased three SNFs formerly leased by Claremont Health Care Holdings, Inc. located in Florida and representing 360 beds, to an existing operator at an initial annual lease rate of $2.5 million. These facilities were added to an existing Master Lease, the initial term of which has been extended ten years to February 2014. The aggregate annual lease rate under this Master Lease, inclusive of the $2.5 million, is $3.9 million.

Mortgages Receivable

Mortgage interest income is recognized as earned over the terms of the related mortgage notes. Reserves are taken against earned revenues from mortgage interest when collection of amounts due become questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account application of security deposits.

On April 6, 2004, we received approximately $4.6 million in proceeds on a mortgage loan payoff. We held mortgages on five facilities located in Missouri, representing 319 beds, which produced approximately $0.5 million of annual interest revenue in 2003.

No provisions for loss on mortgages or notes receivable were recorded during the three-and six-months ended June 30, 2004 and 2003, respectively.

Acquisitions

The table below summarizes the two acquisitions completed during the three months ended June 30, 2004. The purchase price includes transaction costs.

100% Interest Acquired    Acquisition Date    Purchase Price ($000’s)

Three facilities (2 in Vermont,
1 in Connecticut)          April 1, 2004       $26,000

Two facilities in Texas        April 30, 2004       $ 9,400


The acquired properties are included in our results of operations from the respective date of acquisition. The following unaudited pro forma results of operations reflect these transactions as if each had occurred on January 1 of the year presented. In our opinion, all significant adjustments necessary to reflect the effects of the acquisitions have been made.


 
  
Pro Forma
(in thousands, except per share amounts)
   
 
Three Months Ended June 30,
Six Months Ended June 30,
   
 
    
2004
    
2003
    
2004
    
2003
  
   
 
 
 
 
Revenues
  
$
22,431
  
$
22,414
  
$
44,617
  
$
46,741
  
Net income (loss)
  
$
5,971
  
$
7,169
  
$
(3,985
)
$
13,495
  
 
    
 
    
 
    
 
    
 
  
Earnings per share – Basic
  
$
(0.01
)
$
0.06
  
$
(1.22
)
$
0.09
  
   
 
 
 
 
Earnings per share – Diluted
  
$
(0.01
)
$
0.06
  
$
(1.22
)
$
0.09
  
   
 
 
 
 


Closed Facilities

During the three months ended June 30, 2004, we sold one closed SNF located in Illinois for net proceeds of approximately $50 thousand, resulting in a loss of approximately $137 thousand. During the three months ended March 31, 2004, we sold two facilities, one located in Iowa and the other located in Florida, realizing proceeds of approximately $85 thousand, net of closing costs and other expenses, resulting in a net loss of approximately $351 thousand. In accordance with SFAS No. 144, the $137 thousand and the $351 thousand realized net losses are included in discontinued operations in our consolidated statements of operations for their respective time periods. (See Note 11 – Discontinued Operations).

At June 30, 2004, there were three closed properties that were not under contract for sale with a total net book value of approximately $1.8 million. At this time, we determined that no provisions for impairment are needed on the three remaining investments. We intend to sell the facilities as soon as practicable; however, there can be no assurance if, or when, these sales will be completed on terms that allow us to realize the carrying value of the assets. These properties are included in “Land and buildings at cost” in our consolidated balance sheet.


Other Non–Core Assets

·In connection with refinancing our $225 million senior secured credit facility, we sold our $200 million interest rate cap on March 31, 2004. Net proceeds from the sale totaled approximately $3.5 million and resulted in a loss of approximately $6.5 million, which was recorded in the first quarter of 2004 and is included in interest refinancing costs in our consolidated statement of operations.

·Under our restructuring agreement with Sun, we received the right to convert deferred base rent owed to us, totaling approximately $7.8 million, into 800,000 shares of Sun’s common stock, subject to certain non-dilution provisions and the right of Sun to pay cash in an amount equal to the value of that stock in lieu of issuing stock to us.

On March 30, 2004, we notified Sun of our intention to exercise our right to convert the deferred base rent into fully paid and non-assessable shares of Sun’s common stock. On April 16, 2004, we received a stock certificate for 760,000 restricted shares of Sun’s common stock and cash in the amount of approximately $0.5 million in exchange for the remaining 40,000 shares of Sun’s common stock. On July 23, 2004, Sun registered these shares with the Securities and Exchange Commission (“SEC”). We are accounting for the remaining 760,000 shares as “available for sale” marketable securities with changes in market value recorded in other comprehensive income.


NOTE 3 – CONCENTRATION OF RISK

As of June 30, 2004, our portfolio of investments consisted of 208 healthcare facilities, located in 29 states and operated by 39 third-party operators. Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled $842.2 million at June 30, 2004, with 97.2% of our real estate investments related to long-term care facilities. This portfolio is made up of 157 long-term healthcare facilities and two rehabilitation hospitals owned and leased to third parties, fixed rate mortgages on 46 long-term healthcare facilities and three long-term healthcare facilities that were recovered from customers and are currently closed. At June 30, 2004, we also held other investments of approximately $36.4 million, including $23.0 million of notes receivable, net of allowance.

Approximately 38.8% of our real estate investments are operated by four public companies: Sun (18.6%), Advocat, Inc. (“Advocat”) (12.4%), Mariner Health Care, Inc. (7.1%) and Emeritus Corporation (0.7%). The four largest private operators represent 6.5%, 5.7%, 4.4%, and 3.8%, respectively, of our investments. No other operator represents more than 2.9% of our investments. The three states in which we have our highest concentration of investments are Florida (15.1%), California (7.9%) and Ohio (7.0%).

For the three-month period ended June 30, 2004, our revenues from core operations totaled $22.3 million, of which approximately $5.5 million was derived from Sun (24.4%) and $3.0 million from Advocat (13.3%). For the six-month period ended June 30, 2004, our revenues from core operations totaled $43.6 million, of which approximately $10.9 million was derived from Sun (25.0%) and $5.9 million from Advocat (13.6%).


NOTE 4 – DIVIDENDS

In order to qualify as a real estate investment trust (“REIT”), we are required to distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (i) 90% of our "REIT taxable income" (computed without regard to the dividends paid deduction and our net capital gain), and (ii) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income. In addition, if we dispose of any built-in gain asset during a recognition period, we will be required to distribute at least 90% of the built-in gain (after tax), if any, recognized on the disposition of such asset. Such distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our tax return for such year and paid on or be fore the first regular dividend payment after such declaration. In addition, such distributions are required to be made pro rata, with no preference to any share of stock as compared with other shares of the same class, and with no preference to one class of stock as compared with another class except to the extent that such class is entitled to such a preference. To the extent that we do not distribute all of our net capital gain or do distribute at least 90%, but less than 100% of our "REIT taxable income," as adjusted, we will be subject to tax thereon at regular ordinary and capital gain corporate tax rates, respectively. In addition, our $175 million revolving senior secured credit facility (“Credit Facility”) has certain financial covenants which limit the distribution of dividends paid during a fiscal quarter to no more than 95% of our immediately prior fiscal quarter’s funds from operations (“FFO”) as defined in the loan agreement governing our Credit Facility (the “Loan Agreement”), unless a greater distribution is required to maintain REIT status. The Loan Agreement, in general, defines FFO as net income (or loss), plus depreciation and amortization and shall be adjusted for charges related to (i) restructuring our debt, (ii) redemption of preferred stock, (iii) litigation charges up to $5.0 million, (iv) non-cash charges for accounts and notes receivable up to $5.0 million, and (v) non-cash impairment charges.

On July 20, 2004 our Board of Directors announced a common stock dividend of $0.18 per share. The common stock dividend will be paid August 16, 2004 to common stockholders of record on July 30, 2004. In addition our Board of Directors also declared its regular quarterly dividends for our 8.625% Series B cumulative preferred stock (the “Series B preferred stock”) and 8.375% Series D cumulative redeemable preferred stock (the “Series D preferred stock”) to preferred stockholders of record on July 30, 2004. These holders of the Series B preferred stock and the Series D preferred stock will be paid dividends in the amount of $0.53906 and $0.52344, per preferred share, respectively, on August 16, 2004. The liquidation preference for each of our Series B preferred stock and Series D preferred stock is $25.00 per share. Regular quarterly preferred di vidends represent dividends for the period May 1, 2004 through July 31, 2004 for both the Series B preferred stock and the Series D preferred stock.

On March 29, 2004, our Board of Directors declared regular quarterly dividends for all classes of preferred stock, payable on May 17, 2004 to preferred stockholders of record on April 30, 2004. These holders of the Series B preferred stock and the Series D preferred stock received dividends in the amount of $0.53906 and $0.47109, per preferred share, respectively, on May 17, 2004. Regular quarterly preferred dividends represent dividends for the period February 1, 2004 through April 30, 2004 for the Series B preferred stock and February 10, 2004 through April 30, 2004 for the Series D preferred stock. On April 20, 2004, our Board of Directors announced a common stock dividend of $0.18 per share, which is a $0.01 per share, or 5.9% increase over the previous quarter’s dividend. The common stock dividend was paid May 17, 2004 to common stockholders of record on April 30, 2004. At the date of this filing, we had approximately 46.6 million shares outstanding.

On April 30, 2004, we fully redeemed our 9.25% Series A preferred stock (“Series A preferred stock”) (NYSE:OHI PrA; CUSIP: 681936209) for $25.00 per share, plus $0.57813 per share in accrued and unpaid dividends through the redemption date, for an aggregate redemption price of $25.57813 per share. Dividends on the shares of Series A preferred stock ceased to accrue from and after the redemption date, after which the Series A preferred stock will no longer be outstanding and holders of the Series A preferred stock will have only the right to receive the redemption price.


NOTE 5 – TAXES

For the three and six months ended June 30, 2004, no provision for income tax was recorded due to our intention to distribute to our stockholders at least 100% of our estimated 2004 taxable income and to continue to qualify as a REIT. We are permitted to own up to 100% of a “taxable REIT subsidiary” or a “TRS.” Currently we have two taxable REIT subsidiaries that are taxable as corporations and that pay federal, state and local income tax on their net income at the applicable corporate rates. These taxable subsidiaries had net operating loss carry-forwards as of June 30, 2004 of $14.6 million. These loss carry-forwards were fully reserved with a valuation allowance due to uncertainties regarding realization.


NOTE 6 – STOCK-BASED COMPENSATION

We account for stock options using the intrinsic value method as defined by Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. Under the terms of the 2000 Stock Incentive Plan (the “2000 Plan”), we reserved 3,500,000 shares of common stock for grants to be issued during a period of up to ten years. Options granted under the 2000 Plan are exercisable at the market price at the date of grant and expire five years after date of grant for over 10% owners and ten years from the date of grant for less than 10% owners. Directors' shares vest over three years, while other grants vest over five years or as defined in an employee’s contract. Directors, officers and employees are eligible to participate in the 2000 Plan. At June 30, 2004, th ere were 1,159,078 outstanding options granted to 17 eligible participants under the 2000 Plan. Additionally, 355,655 shares of restricted stock have been granted under the provisions of the 2000 Plan, and as of June 30, 2004, there were no shares of restricted stock outstanding under the 2000 Plan.

On April 20, 2004, our Board of Directors approved the 2004 Stock Incentive Plan (the “2004 Plan”), which was subsequently approved by our stockholders at our annual meeting held on June 3, 2004. Under the terms of the 2004 Plan, we reserved 3,000,000 share of common stock for grants to be issued during a period of up to ten years. Options granted under the 2004 Plan will be exercisable at the market price at the date of grant and will expire five years after date of grant for over 10% owners and ten years from the date of grant for less than 10% owners. As of June 30, 2004, there were no grants or awards made under the 2004 Plan. Directors, officers and employees are eligible to participate in the 2004 Plan.

Statement of Financial Accounting Standard No. 148, Accounting for Stock-Based Compensation – Transition and Disclosure, which was effective January 1, 2003, requires certain disclosures related to our stock-based compensation arrangements.
The following table presents the effect on net income and earnings per share if we had applied the fair value recognition provisions of SFAS No. 123, Accounting for Stock-Based Compensation, to our stock-based compensation.

 
  
Three Months Ended
Six Months Ended
 
  
June 30,
June 30,
   
 
  
2004
2003
2004
2003
   
 
  
(in thousands, except per share amounts) 
(in thousand, except per share amounts)
Net (loss) income available to common stockholders
  
$
(376
)
$
1,800
  
$
(54,103
)
$
2,756
  
Add: Stock-based compensation expense included in net (loss) income available to common stockholders   
    
—
    
—
    
—
    
—
  
   
 
 
 
 
 
    
(376
)
  
1,800
  
(54,103
)
  
2,756
  
Less: Stock-based compensation expense determined under the fair value based method for all awards   
    
6
    
73
    
12
    
93
  
   
 
 
 
 
Pro forma net (loss) income available to common stockholders
  
$
(382
)
  $
1,727
  
$
(54,115
)
$
2,663
  
   
 
 
 
 
Earnings per share:
    
 
    
 
    
 
    
 
  
Basic, as reported
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 
Basic, pro forma
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 
Diluted, as reported
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 
Diluted, pro forma
  
$
(0.01
)
$
0.05
  
$
(1.23
)
$
0.07
  
   
 
 
 
 

 
     
 

At June 30, 2004, there were 391,015 options currently exercisable with a weighted-average exercise price of $4.50, with exercise prices ranging from $2.32 to $37.20. There are 559,960 shares available for future grants as of June 30, 2004. A breakdown of the options outstanding as of June 30, 2004 by price range is presented below:

 

Option Price
Range
 
Number
Weighted Average
Exercise Price
Weighted Average
Remaining Life (Years)
Number
Exercisable
Weighted Average
Price on Options Exercisable
$2.32 -$3.00
581,760
$2.61
7.12
76,724
$2.36
$3.01 - $3.81
515,816
$3.20
7.40
267,376
$3.20
$6.02 - $9.33
42,501
$6.97
7.82
27,914
$6.88
$20.25 -$37.20
19,001
$28.03
2.99
19,001
$28.03

The Black-Scholes options valuation model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of our employee stock options.


NOTE 7 – FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS

Bank Credit Agreements

On April 30, 2004, we exercised our right to increase the revolving commitments under our Credit Facility by an additional $50 million to $175 million. All other terms of the Credit Facility, which closed on March 22, 2004, remain the same. Bank of America, N.A. serves as Administrative Agent for the Credit Facility.

At June 30, 2004, $35.0 million was outstanding under the Credit Facility and $4.6 million was utilized for the issuance of letters of credit, leaving availability of $135.4 million. The $35.0 million of outstanding borrowings had a blended interest rate of 4.10% at June 30, 2004.

We are required to meet certain property level financial covenants and corporate financial covenants, including prescribed leverage, fixed charge coverage, minimum net worth, limitations on additional indebtedness and limitations on dividend payouts on our long-term borrowings. As of June 30, 2004, we were in compliance with all property level and corporate financial covenants.

Series A Preferred Redemption

On April 30, 2004, we redeemed all outstanding 2.3 million shares of our Series A preferred stock at a price of $25.57813 per share, comprised of the $25 per share liquidation value and accrued dividend. Under FASB-EITF Issue D-42, ‘‘The Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock,” the repurchase of the Series A preferred stock resulted in a non-cash charge to net income available to common stockholders of approximately $2.3 million. On July 9, 2004, we filed articles supplementary with the Maryland Department of Assessments and Taxation to reclassify the redeemed shares of Series A preferred stock as authorized but unissued preferred stock, without designation as to class.

Series C Preferred Stock Repurchase

On February 5, 2004, we announced that Explorer Holdings L.P. (“Explorer”), our then largest stockholder, granted us the option to repurchase up to 700,000 shares of our Series C cumulative preferred stock (“Series C preferred stock”), which were convertible into Omega common shares held by Explorer at a negotiated purchase price of $145.92 per share of Series C preferred stock (or $9.12 per common share on an as converted basis). Explorer further agreed to convert any remaining Series C preferred stock into common stock.

Series D Preferred Stock Offering

On February 10, 2004, we announced the closing of the sale of 4,739,500 shares of Series D preferred stock. The preferred stock was issued at $25 per share and listed on the New York Stock Exchange (“NYSE”) under the symbol “OHI PrD.”

Series C Preferred Stock Redemption and Conversion

We used approximately $102.1 million of the net proceeds from the Series D preferred stock offering to repurchase 700,000 shares of our Series C preferred stock from Explorer. In connection with the closing of the repurchase, Explorer converted its remaining 348,420 Series C preferred stock into approximately 5.6 million shares of our common stock. Following the repurchase and conversion, Explorer held approximately 18.1 million of our common shares.

The combined repurchase and conversion of the Series C preferred stock reduced our preferred dividend requirements, increased our market capitalization and facilitated future financings by simplifying our capital structure. Under FASB-EITF Issue D-42, ‘‘The Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock,” the redemption and conversion of the Series C preferred stock resulted in a non-cash charge to net income available to common stockholders of approximately $38.7 million.

18.1 Million Secondary and 2.7 Million Primary Offering of Omega Common Stock

On March 8, 2004, we announced the closing of an underwritten public offering of 18.1 million shares of our common stock at a price of $9.85 per share owned by Explorer (the “Secondary Offering”). As a result of the Secondary Offering, Explorer no longer owns any shares of our common stock. We did not receive any proceeds from the sale of the shares sold by Explorer.

In connection with the Secondary Offering, we issued approximately 2.7 million additional shares of our common stock at a price of $9.85 per share, less underwriting discounts (the “Over-allotment Offering”), to cover over-allotments relating to the Secondary Offering. We received net proceeds of approximately $22.4 million from the Over-allotment Offering.

$200 Million 7% Senior Unsecured Notes Offering and $125 Million Credit Facility

Effective March 22, 2004, we closed a private offering of $200 million aggregate principal amount of 7% senior unsecured notes due 2014 (the “Initial Notes”) and the Credit Facility provided by Bank of America, N.A., Deutsche Bank AG, UBS Loan Finance, LLC and GE Healthcare Financial Services. We used proceeds from the offering of the Initial Notes offering to replace and terminate our previous $225 million senior secured credit facility and $50 million acquisition credit facility (the “Prior Credit Facility”). The Credit Facility will be used for acquisitions and general corporate purposes. In connection with the termination of the Prior Credit Facility, we recorded a charge of approximately $12.6 million, of which $6.3 million consisted of non-cash charges relating to deferred financing costs of the previous credit facilities. The Initial No tes represent our unsecured senior obligations and have been guaranteed by all of our subsidiaries. The Initial Notes were issued in a private placement transaction.

On June 21, 2004, we filed a registration statement on Form S-4, which was amended on July 26, 2003, under the Securities Act of 1933, as amended (the “Securities Act”), with the SEC offering to exchange up to $200 million aggregate principal amount of our 7% Senior Notes due 2014 (the “Exchange Notes”), for all of our outstanding unregistered Initial Notes. The terms of the Exchange Notes are identical to the terms of the Initial Notes, except that the Exchange Notes will be registered under the Securities Act and therefore freely tradable (subject to certain conditions). The Exchange Notes evidence the same indebtedness as the Initial Notes, and will be guaranteed by certain of our present and future domestic restricted subsidiaries with unconditional guarantees of payment that will rank equally with existing and future senior unsecured debt of such subsidiaries and senior to existing and future subordinated debt of such subsidiaries.

$200 Million Interest Rate Cap Sale

In connection with the repayment and termination of the Prior Credit Facility, we sold our $200 million interest rate cap on March 31, 2004. Net proceeds from the sale totaled approximately $3.5 million and resulted in a loss of approximately $6.5 million, which was recorded in the first quarter of 2004.


NOTE 8 – RELATED PARTY TRANSACTIONS

On February 5, 2004, we entered into a Repurchase and Conversion Agreement with our then largest stockholder, Explorer, pursuant to which Explorer granted us an option to repurchase up to 700,000 shares of our Series C preferred stock at a price of $145.92 per share (or $9.12 per share of common stock on an as-converted basis), on the condition that we purchase a minimum of $100 million on or prior to February 27, 2004. Explorer also agreed to convert all of its remaining shares of Series C preferred stock into share of our common stock upon exercise of the repurchase option.

On February 10, 2004, we sold in a registered direct placement 4,739,500 shares of our Series D preferred stock at a price of $25 per share to a number of institutional investors and other purchasers for net proceeds, after fees and expenses, of approximately $114.9 million. Following the closing of the Series D preferred stock offering, we used approximately $102.1 million of the net proceeds to repurchase 700,000 shares of our Series C preferred stock from Explorer pursuant to the repurchase option. In connection with this transaction, Explorer converted its remaining 348,420 shares of Series C preferred stock into 5,574,720 shares of our common stock. The balance of the net proceeds from the offering was used to redeem approximately 600,000 shares of our Series A preferred stock.

As a result of the Series D preferred stock offering, the application of the proceeds received from the offering to fund the exercise of our repurchase option, and the conversion of the remaining Series C preferred stock into shares of our common stock:


On February 12, 2004, we registered Explorer’s 18,118,246 shares of common stock with the SEC. Explorer sold all of these registered shares pursuant to the registration statement.

In connection with our repurchase of a portion of Explorer’s Series C preferred stock, our results of operations for the first quarter of 2004 included a non-recurring reduction in net income attributable to common stockholders of approximately $38.7 million. This amount reflects the sum of (i) the difference between the deemed redemption price of $145.92 per share of our Series C preferred stock and the carrying amount of $100 per share of our Series C preferred stock multiplied by the number of shares of the Series C preferred stock repurchased upon exercise of our option to repurchase shares of Series C preferred stock and (ii) the cost associated with the original issuance of our Series C preferred stock that was previously classified as additional paid in capital, pro rated for the repurchase. This non-recurring reduction in net income attributable to c ommon stockholders reduced our earnings per share and our reportable funds from operations for the first quarter of 2004.


NOTE 9 – LITIGATION

We are subject to various legal proceedings, claims and other actions arising out of our normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.


We and several of our wholly-owned subsidiaries have been named as defendants in professional liability claims related to our owned and operated facilities. Other third-party managers responsible for the day-to-day operations of these facilities have also been named as defendants in these claims. In these suits, patients of certain previously owned and operated facilities have alleged significant damages, including punitive damages against the defendants. The majority of these lawsuits representing the most significant amount of exposure were settled during the three months ended June 30, 2004. There remain several lawsuits pending that are in various stages of discovery and we are unable to predict the likely outcome of these lawsuits at this time. We continue to vigorously defend these claims and have insured against such claims, subject to self-insured r etentions of various amounts. During the three months ended June 30, 2004, we recorded a $3.0 million charge associated with all settled and outstanding claims.


NOTE 10 – DERIVATIVES

On March 31, 2004, we sold our $200.0 million interest rate cap, realizing net proceeds of approximately $3.5 million, resulting in a loss of approximately $6.5 million, which was recorded during the first quarter of 2004 and is included within the $19.1 million interest expense associated with refinancing activities. An adjustment of $4.5 million to other comprehensive income was recorded as a result of this transaction.


NOTE 11 – DISCONTINUED OPERATIONS

The implementation of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, as of January 1, 2002, requires the presentation of the net operating results of facilities sold during 2004 as income from discontinued operations for all periods presented. We incurred a net loss from discontinued operations of $137 thousand and $491 thousand for the three-and six-month periods ended June 30, 2004, respectively, in the accompanying consolidated statements of operations.
 
     
 

The following table summarizes the results of operations of facilities sold during the three and six months ended June 30, 2004 and 2003, respectively.


 
  
Three Months Ended
Six Months Ended
 
  
June 30,
June 30,
   
 
  
2004
2003
2004
2003
   
 
  
(in thousands)
(in thousands)
Revenues
  
 
 
 
 
Rental income
  
$
—
  
$
255
  
$
—
  
$
511
  
Owned & operated revenue
    
—
    
2
    
—
    
205
  
   
 
 
 
 
Subtotal Revenues
    
—
    
257
    
—
    
716
  
   
 
 
 
 
Expenses
    
 
    
 
    
 
    
 
  
Owned & operated expenses
    
—
    
115
    
—
    
513
  
Depreciation and amortization
    
—
    
127
    
2
    
250
  
   
 
 
 
 
Subtotal expenses
    
—
    
242
    
2
    
763
  
   
 
 
 
 
 
    
 
    
 
    
 
    
 
  
(Loss) income before (loss) gain on sale of assets
    
—
    
15
    
(2
)
  
(47
)
(Loss) on assets sold – net
    
(137
)
  
—
    
(489
)
  
—
  
   
 
 
 
 
(Loss) gain from discontinued operations
  
$
   (137
)
$
   15
  
$
   (491
)
$
   (47
)
   
 
 
 
 


NOTE 12 - EARNINGS PER SHARE

The computation of basic earnings per common share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common stock outstanding during the relevant period. Diluted EPS reflects the potential dilution that could occur from shares issuable through stock-based compensation, including stock options and the conversion of our Series C preferred stock in 2003.

For the three-and six-month periods ended June 30, 2004 there were no dilutive effects from stock options. For the three- and six-month periods ended June 30, 2003 there was a $0.00 and $0.01 dilutive effect from stock options.

 
     
 
Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking Statements, Reimbursement Issues and Other Factors Affecting Future Results

The following discussion should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this document. This document contains forward-looking statement within the meaning of the federal securities laws, including statements regarding potential financings and potential future changes in reimbursement. These statements relate to our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events, performance and underlying assumptions and other statements other than statements of historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology including, but not limited to, terms such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms o r the negative thereof. These statements are based on information available on the date of this filing and only speak as to the date hereof and no obligation to update such forward-looking statements should be assumed. Our actual results may differ materially from those reflected in the forward-looking statements contained herein as a result of a variety of factors, including, among other things:

  1. uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels;
  2. the ability of any operators in bankruptcy to reject unexpired lease obligations, modify the terms of our mortgages and impede our ability to collect unpaid rent or interest during the process of a bankruptcy proceeding and retain security deposits for the debtors’ obligations;
  3. our ability to sell closed assets on a timely basis and on terms that allow us to realize the carrying value of these assets;
  4. our ability to negotiate appropriate modifications to the terms of our credit facilities;
  5. our ability to manage, re-lease or sell any owned and operated facilities;
  6. the availability and cost of capital;
  7. competition in the financing of healthcare facilities;
  8. regulatory and other changes in the healthcare sector;
  9. the effect of economic and market conditions generally and, particularly, in the healthcare industry;
  10. changes in interest rates;
  11. the amount and yield of any additional investments;
  12. changes in tax laws and regulations affecting real estate investment trusts; and
  13. changes in the ratings of our debt and preferred securities.


Overview

As of June 30, 2004, our portfolio of investments consisted of 208 healthcare facilities, located in 29 states and operated by 39 third-party operators. Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled $842.2 million at June 30, 2004, with 97.2% of our real estate investments related to long-term care facilities. This portfolio is made up of 157 long-term healthcare facilities and two rehabilitation hospitals owned and leased to third parties, fixed rate mortgages on 46 long-term healthcare facilities and three long-term healthcare facilities that were recovered from customers and are currently closed. At June 30, 2004, we also held other investments of approximately $36.4 million, including $23.0 million of notes receivable, net of allowance.

 
     
 
Highlights

The following significant events occurred during the three-month period ended June 30, 2004.

Financing and Borrowing


Dividends

·   Declared a common dividend of $0.18 per common share.

New Investments

·  Completed two separate acquisitions totaling $35 million of new investments.


Asset sales

·  Sold one closed facility, realizing proceeds of approximately $50 thousand, net of closing costs and other expenses, resulting in a loss of approximately $137 thousand.

Medicare Reimbursement

Nearly all of our properties are used as healthcare facilities; therefore, we are directly affected by the risk associated with the healthcare industry. Our lessees and mortgagors, as well as any facilities owned and operated for our own account; derive a substantial portion of their net operating revenues from third-party payors, including the Medicare and Medicaid programs. These programs are highly regulated by federal, state and local laws, rules and regulations, and subject to frequent and substantial change. The Balanced Budget Act of 1997 (the “Balanced Budget Act”) significantly reduced spending levels for the Medicare and Medicaid programs. Due to the implementation of the terms of the Balanced Budget Act, effective July 1, 1998, the majority of skilled nursing facilities (“SNFs”) shifted from payments based on reasonable cost to a pr ospective payment system for services provided to Medicare beneficiaries. Under the prospective payment system, SNFs are paid on a per diem prospective case-mix adjusted basis for all covered services. Implementation of the prospective payment system has affected each long-term care facility to a different degree; depending upon the amount of revenue such facility derives from Medicare patients.

Legislation adopted in 1999 and 2000 increased Medicare payments to nursing facilities and specialty care facilities on an interim basis. Section 101 of the Balanced Budget Refinement Act of 1999 (the “Balanced Budget Refinement Act”) included a 20% increase for 15 patient acuity categories (known as Resource Utilization Groups (“RUGS”)) and a 4% across the board increase of the adjusted federal per diem payment rate. The 20% increase was implemented in April 2000 and will remain in effect until the implementation of refinements in the current RUG case-mix classification system to more accurately estimate the cost of non-therapy ancillary services. The 4% increase was implemented in April 2000 and expired October 1, 2002.

The Benefits Improvement and Protection Act of 2000 (the “Benefits Improvement and Protection Act”) included a 16.7% increase in the nursing component of the case-mix adjusted federal periodic payment rate and a 6.7% increase in the 14 RUG payments for rehabilitation therapy services. The 16.7% increase was implemented in April 2000 and expired October 1, 2002. The 6.7% increase is an adjustment to the 20% increase granted in the Balanced Budget Refinement Act and spreads the funds directed at three of the 15 RUGs to an additional 11 rehabilitation RUGs. The increase was implemented in April 2001 and will remain in effect until the implementation of refinements in the current RUG case-mix classification system.

The expiration of the 4% and 16.7% increases under these statutes as of October 1, 2002 has had an adverse impact on the revenues of the operators of nursing facilities and has negatively impacted some operators’ ability to satisfy their monthly lease or debt payments to us. Medicare reimbursement could be further reduced when the Centers for Medicare & Medicaid Services (“CMS”) completes its RUG refinement, thereby eliminating the temporary 20% and 6.7% increases also established under these statutes.

On August 4, 2003, CMS published the payment rates for SNFs for federal fiscal year 2004 (effective October 1, 2003 through September 30, 2004). CMS announced that the SNF update would be a 3.0% increase in Medicare payments for federal fiscal year 2004. In addition, CMS announced that the two temporary payment increases – the 20% and 6.7% add-ons for certain payment categories – will continue to be effective for federal fiscal year 2004.

Also in the August 4, 2003 announcement, CMS confirmed its intention to incorporate a forecast error adjustment that takes into account previous years’ update errors. According to CMS, there was a cumulative SNF market basket, or inflation adjustment, forecast error of 3.26% for federal fiscal years 2000 through 2002. As a result, CMS has increased the national payment rate by an additional 3.26% above the 3.0% increase for federal fiscal year 2004.

CMS currently is developing its proposed payment rates for SNFs for federal fiscal year 2005 (effective October 1, 2004 through September 30, 2005). Although the proposed rule is expected to be released soon, at this time we have no information regarding the payment rates CMS intends to propose or any other policy changes that may be issued in the proposed rule.

A temporary increase in the per diem amount paid to SNFs for residents who have AIDS will become effective on October 1, 2004. This temporary payment increase, which will remain in place subject to CMS’ discretion, arises from the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (“Medicare Modernization Act”), Pub. L. 108-173.

The Medicare Modernization Act also temporarily reinstituted a moratorium on the application of a reimbursement cap on outpatient rehabilitative services. The therapy cap limits reimbursement to $1,950 for physical therapy and speech-language pathology services provided on an outpatient basis. Congress first enacted a moratorium on the implementation of a reimbursement cap from January 1, 2000 until January 1, 2003. CMS enforced the reimbursement cap from September 1, 2003 through December 7, 2003, at which point Congress reinstituted the moratorium under the Medicare Modernization Act. The moratorium remains in place through December 31, 2005, and its future beyond that date is unclear at this point.

CMS released a proposed rule in February 2003 that, if implemented, would limit Medicare reimbursement to certain providers, including SNFs, for bad debt arising from unpaid beneficiary deductibles and coinsurance amounts. In the proposed rule, CMS indicated that reimbursement rates would be reduced by 10% each year for three years until reimbursement rates to SNFs for Medicare bad debt equal 70% of reimbursement rates during federal fiscal year 2003. CMS has not issued a final rule on this issue, and we cannot predict whether CMS will implement these proposed policies or when the final rule may be issued. However, extensive cuts in Medicare payments for bad debt could have a material adverse effect on our operators’ financial condition and result of operations, which could adversely affect their ability to meet their payment obligation to us.

Due to the temporary nature of the 20% and 6.7% payment increases established under the Balanced Budget Refinement Act and the Benefits Improvement and Protection Act, we cannot be assured that the federal reimbursement will remain at levels comparable to present levels and that such reimbursement will be sufficient for our lessees or mortgagors to cover all operating and fixed costs necessary to care for Medicare and Medicaid patients. We also cannot be assured that there will be any future legislation to increase payment rates for SNFs. If payment rates for SNFs are not increased in the future, some of our lessees and mortgagors may have difficulty meeting their payment obligations to us.

Medicaid and Other Third-Party Reimbursement

Each state has its own Medicaid program that is funded jointly by the state and federal government. Federal law governs how each state manages its Medicaid program, but there is wide latitude for states to customize Medicaid programs to fit the needs and resources of its citizens. Rising Medicaid costs and decreasing state revenues caused by current economic conditions have prompted an increasing number of states to cut or consider reductions in Medicaid funding as a means of balancing their respective state budgets. Existing and future initiatives affecting Medicaid reimbursement may reduce utilization of (and reimbursement for) services offered by the operators of our properties. In 2003, many states announced actual or potential budget shortfalls, and many budget forecasts in 2004 appear similar. As a result of these budg et shortfalls, many states have announced that they are implementing or considering implementing “freezes” or cuts in Medicaid reimbursement rates, including rates paid to SNF providers, or reductions in Medicaid enrollee benefits, including long-term care benefits. We cannot predict the extent to which Medicaid rate freezes or cuts or benefit reductions will ultimately be adopted, the number of states that will adopt them or the impact of such adoption on our operators. However, extensive Medicaid rate cuts or freezes or benefit reductions could have a material adverse effect on our operators’ liquidity, financial condition and results of operations, which could adversely affect their ability to make lease or mortgage payments to us.

On May 28, 2003, the federal Jobs and Growth Tax Relief Reconciliation Act (the “Tax Relief Act”) was signed into law, which included an increase in Medicaid federal funding for five fiscal quarters (April 1, 2003 through June 30, 2004). In addition, the Tax Relief Act provides state fiscal relief for federal fiscal years 2003 and 2004 to assist states with funding shortfalls. These temporary federal funding provisions were considered to have partially mitigated state Medicaid funding reductions through federal fiscal year 2004. The temporary Medicaid funding provided under the Tax Relief Act expired on June 30, 2004, and although federal legislation has been introduced in Congress to reinstitute the funding, it is unknown whether such legislation will be enacted, what level of funding would be provided if the legislation was enacted, or how great an ef fect this funding could have on mitigating Medicaid funding reductions.

In addition, private payors, including managed care payors, are increasingly demanding discounted fee structures and the assumption by healthcare providers of all or a portion of the financial risk of operating a healthcare facility. Efforts to impose greater discounts and more stringent cost controls are expected to continue. Any changes in reimbursement policies which reduce reimbursement levels could adversely affect the revenues of our lessees and mortgagors and thereby adversely affect those lessees' and mortgagors' abilities to make their monthly lease or debt payments to us.

Fraud and Abuse
 
There are various extremely complex and largely uninterpreted federal and state laws governing a wide array of referrals, relationships and arrangements and prohibiting fraud by healthcare providers, including criminal provisions that prohibit filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, or failing to refund overpayments or improper payments. Governments are devoting increasing attention and resources to anti-fraud initiatives against healthcare providers.  Penalties for health care fraud have been increased and expanded over recent years, including broader provisions for the exclusion of providers from the Medicare and Medicaid programs, and the Office of Inspector General of the U.S. Department of Health and Human Services, in cooperation with other federal and state agencies, continues to focus on the activities of skilled nursing facilities in certain states in which we have properties. In addition, the federal False Claims Act allows a private individual with knowledge of fraud to bring a claim on behalf of the federal government and earn a percentage of the federal government’s recovery. Because of these incentives, these so-called “whistleblower’’ suits have become more frequent. The violation of any of these regulations by an operator may result in the imposition of fines or other penalties that could jeopardize that operator’s ability to make lease or mortgage payments to us or to continue operating its facility.
 
Legislative and Regulatory Developments.
 
Each year, legislative proposals are introduced or proposed in Congress, state legislatures as well as by federal and state agencies, which, if implemented, could result in major changes in the health care system, either nationally or at the state level.  In addition, regulatory proposals and rules are released on an ongoing basis that may have major impacts on the health care system generally and the industries in which our operators do business.  Legislative and regulatory developments can be expected to occur on an ongoing basis at the local, state and federal levels that have direct or indirect impacts on the policies governing the reimbursement levels paid to our facilities by public and private third-party payors, the costs of doing business and the threshold requirements that must be met for facilities to continue operation or to expand. < /DIV>
 
The Medicare Modernization Act, which is one example of such legislation, was enacted in December 2003.  The significant expansion of other benefits for Medicare beneficiaries under this Act, such as the prescription drug benefit, could result in financial pressures on the Medicare program that might result in future legislative and regulatory changes with impacts for our operators.  Although the creation of a prescription drug benefit for Medicare beneficiaries was expected to generate fiscal relief for state Medicaid programs, the structure of the benefit and costs associated with its implementation and administration through the states may mitigate relief for states that was anticipated.
 
CMS also launched the Nursing Home Quality Initiative program in 2002, which requires nursing homes participating in Medicare to provide consumers with comparative information about the quality of care at the facility.  In the event any of our operators do not maintain the same or superior levels of quality care as their competitors, patients could choose alternate facilities, which could adversely impact our operators’ revenues.  In addition, the reporting of such information could lead in the future to reimbursement policies that reward or penalize facilities on the basis of the reported quality of care parameters.
 
Other proposals under consideration include efforts by individual states to control costs by decreasing state Medicaid reimbursements in the current or future fiscal years and federal legislation addressing various issues, such as protecting consumers in managed care plans, improving quality of care and reducing medical errors throughout the health care industry.  We cannot accurately predict whether any proposals will be adopted or, if adopted, what effect, if any, these proposals would have on operators and, thus, our business.

Potential Risks from Bankruptcies

Our lease arrangements with operators who operate more than one of our facilities are generally made pursuant to a single master lease (“Master Lease”) covering all of that operator’s facilities. Although each lease or Master Lease provides that we may terminate the Master Lease upon the bankruptcy or insolvency of the tenant, the Bankruptcy Reform Act of 1978, as amended (“Bankruptcy Act”) provides that a trustee in a bankruptcy or reorganization proceeding under the Bankruptcy Act, or a debtor-in-possession in a reorganization, has the power and the option to assume or reject the unexpired lease obligations of a debtor-lessee. In the event that the unexpired lease is assumed on behalf of the debtor-lessee, all the rental obligations generally would be entitled to a priority over other unsecured claims. However, the court also has the po wer to modify a lease if a debtor-lessee, in a reorganization, were required to perform certain provisions of a lease that the court determined to be unduly burdensome. It is not possible to determine at this time whether or not any of our leases or Master Leases contains any such provision. If a lease is rejected, the lessor has a general unsecured claim limited to any unpaid rent already due plus an amount equal to the rent reserved under the lease, without acceleration, for the greater of one year or 15% of the remaining term of such lease, not to exceed three years.
Generally, with respect to our mortgage loans, the imposition of an automatic stay under the Bankruptcy Act precludes us from exercising foreclosure or other remedies against the debtor. Pre-petition creditors generally do not have rights to the cash flows from the properties underlying the mortgages. The timing of the collection from mortgagors in bankruptcy depends on negotiating an acceptable settlement with the mortgagor (and subject to approval of the bankruptcy court) or the order of the bankruptcy court in the event a negotiated settlement cannot be achieved. A mortgagee also is treated differently from a landlord in three key respects. First, the mortgage loan is not subject to assumption or rejection because it is not an executory contract or a lease. Second, the mortgagee's loan may be divided into (1) a secured loan for the portion of the mortgage debt that does not exceed the value of the property and (2) a general unsecured loan for the portion of the mortgage debt that exceeds the value of the property. A secured creditor such as ourselves is entitled to the recovery of interest and costs only if, and to the extent that, the value of the collateral does not exceed the amount owed. If the value of the collateral exceeds the amount of the debt, interest and allowed costs may not be paid during the bankruptcy proceeding, but accrue until confirmation of a plan of reorganization or such other time as the court orders. If the value of the collateral held by a senior creditor is less than the secured debt, interest on the loan for the time period between the filing of the case and confirmation may be disallowed. Finally, while a lease generally would either be rejected or assumed with all of its benefits and burdens intact, the terms of a mortgage, including the rate of interest and the timing of principal payments, may be modified if the debtor is able to a ffect a "cram down" under the Bankruptcy Act.

The receipt of liquidation proceeds or the replacement of an operator that has defaulted on its lease or loan could be delayed by the approval process of any federal, state or local agency necessary for the transfer of the property or the replacement of the operator licensed to manage the facility. In addition, some significant expenditures associated with real estate investment, such as real estate taxes and maintenance costs, are generally not reduced when circumstances cause a reduction in income from the investment. In order to protect our investments, we may take possession of a property or even become licensed as an operator, which might expose us to successor liability to government programs or require us to indemnify subsequent operators to whom we might transfer the operating rights and licenses. Third-party payors may also suspend payments to us followi ng foreclosure until we receive the required licenses to operate the facilities. Should such events occur, our income and cash flow from operations would be adversely affected.

Concentration of Risk

For the three-month period ended June 30, 2004, our operating revenues totaled $22.3 million, of which approximately $5.5 million derived from Sun Healthcare Group, Inc. (“Sun”) (24.4%) and $3.0 million from Advocat Inc. (“Advocat”) (13.3%). For the six-month period ended June 30, 2004, our operating revenues totaled $43.6 million, of which $10.9 million derived from Sun (25.0%) and $5.9 million from Advocat (13.6%). Approximately 38.8% of our real estate investments are operated by four public companies: Sun (18.6%), Advocat (12.4%), Mariner Health Care, Inc. (7.1%) and Emeritus Corporation (0.7%). The four largest private operators represent 6.5%, 5.7%, 4.4%, and 3.8%, respectively, of our investments. No other operator represents more than 2.9% of our investments. The three states in which we have our highest concentration of investments ar e Florida (15.1%), California (7.9%) and Ohio (7.0%).

Healthcare Investment Risks

The possibility that the healthcare facilities will not generate income sufficient to meet operating expenses or will yield returns lower than those available through investments in comparable real estate or other investments are additional risks of investing in healthcare-related real estate. Income from properties and yields from investments in such properties may be affected by many factors, including changes in governmental regulation (such as zoning laws), general or local economic conditions (such as fluctuations in interest rates and employment conditions), the available local supply and demand for improved real estate, a reduction in rental income as the result of an inability to maintain occupancy levels, natural disasters (such as earthquakes and floods) or similar factors.

General Real Estate Risks

Real estate investments are relatively illiquid and, therefore, tend to limit our ability to vary our portfolio promptly in response to changes in economic or other conditions. Thus, if the operation of any of our properties becomes unprofitable due to competition, age of improvements or other factors such that the lessee or borrower becomes unable to meet its obligations on the lease or mortgage loan, the liquidation value of the property may be substantially less, particularly relative to the amount owed on any related mortgage loan, than would be the case if the property were readily adaptable to other uses.



Critical Accounting Policies and Estimates

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and a summary of our significant accounting policies is included in Note 2 of our 2003 Form 10-K. Note 1 to the accompanying consolidated financial statements includes a summary of recent accounting pronouncements and their actual or expected impact on our consolidated financial statements. Our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period.

We have identified four significant accounting policies which we believe are critical accounting policies. These critical accounting policies are those that have the most impact on the reporting of our financial condition and those requiring significant judgments and estimates. With respect to these critical accounting policies, we believe the application of judgments and assessments is consistently applied and produces financial information that fairly presents the results of operations for all periods presented. Our actual results may differ from these estimates. The four critical accounting policies are:

Revenue Recognition

With the exception of one Master Lease, rental income and mortgage interest income are recognized as earned over the terms of the related Master Leases and mortgage notes, respectively. Such income includes periodic increases based on pre-determined formulas (i.e., such as increases in the Consumer Price Index (“CPI”)) as defined in the Master Leases and mortgage loan agreements. Reserves are taken against earned revenues from leases and mortgages when collection becomes questionable or when negotiations for restructurings of troubled operators resulting in significant uncertainty regarding ultimate collection. The amount of the reserve is estimated based on what management believes will be collected. When collection is uncertain, lease revenues are recorded as received, after taking into account application of security deposits. Interest income on impa ired mortgage loans is recognized as received after taking into account application of security deposits.

The one Master Lease not recognized as earned over the term of the lease is recognized on a straight-line basis. We recognize the minimum base rental revenue under this Master Lease on a straight-line basis over the term of the related lease. Accrued straight-line rents represent the rental revenue recognized in excess of rents due under the lease agreements at the balance sheet date.

Gains on sales of real estate assets are recognized pursuant to the provisions of SFAS No. 66, “Accounting for Sales of Real Estate.” The specific timing of the recognition of the sale and the related gain is measured against the various criteria in SFAS No. 66 related to the terms of the transactions and any continuing involvement associated with the assets sold. To the extent the sales criteria are not met, we defer gain recognition until the sales criteria are met.

 
     
 
Depreciation and Asset Impairment

Under GAAP, real estate assets are stated at the lower of depreciated cost or fair value, if deemed impaired. Depreciation is computed on a straight-line basis over the estimated useful lives of 25 to 40 years for buildings and improvements. Management periodically, but not less than annually, evaluates our real estate investments for impairment indicators; including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as market conditions, operator performance and legal structure. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are less than the carrying values of the assets. If the sum of the expected future undiscounted cash flow, including sales proceeds, is less than carrying value, then an adjustment is made to the net carrying value of the leased properties and other long-lived assets to the present value of expected future undiscounted cash flows. The fair value of the real estate investment is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.

If we decide to sell rental properties or land holdings, we evaluate the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell and an impairment loss is recognized. Our estimates of cash flow and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties and where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Changes in estimated future cash flows due to changes in our plans or view of market and economic conditions could result in recognition of additional impairment losses, which, under applicable acc ounting guidance, could be substantial.

If events or circumstances indicate that the fair value of an investment has declined below its carrying value and we consider the decline to be “other than temporary,” the investment is written down to fair value and an impairment loss is recognized.

Loan Impairment

Management periodically, but not less than annually, evaluates our outstanding loans and notes receivable. When management identifies potential loan impairment indicators, such as non-payment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator or other circumstances that may impair full execution of the loan documents, then the loan is written down to the present value of the expected future cash flows. In cases where expected future cash flows cannot be estimated, the loan is written down to the fair value of the collateral. The fair value of the loan is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses.

Discontinued Operations

We adopted SFAS No. 144 effective January 1, 2002 which requires among other things, that the operating results of specified real estate assets which have been sold subsequent to January 1, 2002, or otherwise qualify as held for disposition (as defined by SFAS No. 144), be reflected as discontinued operations in the consolidated statements of operations for all periods presented. We held no assets that qualified as held for disposition, as defined by SFAS No. 144, as of June 30, 2004 and December 31, 2003.

 
     
 
Results of Operations

The following is our discussion of the consolidated results of operations, financial position and liquidity and capital resources, which should be read in conjunction with our consolidated financial statements and accompanying notes.

Three Months Ended June 30, 2004 and 2003

Operating Revenues

Our operating revenues for the three months ended June 30, 2004 totaled $22.3 million, an increase of $0.9 million, from the same period in 2003. When excluding nursing home revenues of owned and operated assets, revenues increased by $1.9 million. The $1.9 million increase was primarily a result of new investments made in April 2004, re-leasing and restructuring activities completed throughout 2003 and during the first quarter of 2004, as well as normal contractual increases in rents.

Detail changes in operating revenues during the three months ended June 30, 2004 are as follows:


Operating Expenses

Operating expenses for the three months ended June 30, 2004 totaled $7.2 million, a decrease of approximately $1.5 million from the same period in 2003. When excluding nursing home expenses of owned and operated assets, a decrease in expenses of $0.5 million was primarily due to reductions in general and administrative and legal costs.
 
Detail changes in our operating expenses during the three months ended June 30, 2004 are as follows:


Other Income (Expense)


Other 
  
   ·   During the three months ended June 30, 2004, we sold one closed SNF located in Illinois for net proceeds of approximately $50,000, resulting in a loss of approximately $137,000.

Six Months Ended June 30, 2004 and 2003

Operating Revenues

Our operating revenues for the six months ended June 30, 2004 totaled $43.6 million, a decrease of $1.3 million from the same period in 2003. When excluding nursing home revenues of owned and operated assets, revenues increased $1.1 million. The $1.1 million increase was primarily a result of new investments made in April 2004, re-leasing and restructuring activities completed throughout 2003 and during the first quarter of 2004, as well as normal contractual increases in rents.

Detail changes in operating revenues during the six months ended June 30, 2004 are as follows:


Operating Expenses

Operating expenses for the six months ended June 30, 2004 totaled $14.4 million, a decrease of approximately $4.2 million from the same period in 2003. When excluding nursing home expenses of owned and operated assets, expenses decreased $0.7 million, primarily due to reductions in general and administrative and legal costs.

Detail changes in our operating expenses during the six months ended June 30, 2004 are as follows:

Other Income (Expense)


Other   


Loss from Discontinued Operations

Discontinued operations relate to properties we disposed of in 2004 and are accounted for as discontinued operations under SFAS No. 144. The sale of three closed facilities resulted in a net loss of approximately $491 thousand. In accordance with SFAS No. 144, the $491 thousand realized net loss is reflected in our consolidated statements of operations as discontinued operations.

Funds From Operations

Our funds from operations available to common stockholders (“FFO”) for the three- and six-months ended June 30, 2004, was $5.1 million and a deficit of $43.0 million, respectively, a decrease of $3.3 million and $60.4 million, as compared to $8.5 million and $17.4 million for the same period in 2003.

We calculate and report FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts (“NAREIT”), and consequently, FFO is defined as net income available to common stockholders, adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization. FFO available to common stockholders is the lower of funds from operations and funds from operations adjusted for the assumed conversion of Series C cumulative preferred stock (the “Series C preferred stock”) and the exercise of in-the-money stock options. We believe that FFO is an important supplemental measure of our operating performance. Because the historical cost accounting convention used for real es tate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. The term FFO was designed by the real estate industry to address this issue. FFO herein is not necessarily comparable to FFO of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from us.

We use FFO as one of several criteria to measure operating performance of our business. We further believe that by excluding the effect of depreciation, amortization and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance. FFO can facilitate comparisons of operating performance between periods and between other REITs. We offer this measure to assist the users of our financial performance under GAAP and should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP. Investor and potential investors in our securities should not rely on this measure as a substitute for any GAAP measure, including net income.

In February 2004, NAREIT informed its member companies that it was adopting the position of the Securities and Exchange Commission (“SEC”) with respect to asset impairment charges and would no longer recommend that impairment write-downs be excluded from FFO. In the tables included in this disclosure, we have applied this interpretation and have not excluded asset impairment charges in calculating our FFO. As a result, our FFO and FFO available to common stockholders may not be comparable to similar measures reported in previous disclosures. According to NAREIT, there is inconsistency among NAREIT member companies as to the adoption of this interpretation of FFO. Therefore, a comparison of our FFO results to another company's FFO results may not be meaningful.

The following table presents our FFO results reflecting the impact of asset impairment charges (the SEC's interpretation) for the three and six months ended June 30, 2004 and 2003:

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2004
 
2003
 
2004
 
2003
 
(in thousands)
 
(in thousands)
 
 
 
 
 
 
 
 
Net (loss) income available to common        
$ (376)
 
$ 1,800
 
$ (54,103)
 
$ 2,756
Add back loss from real estate dispositions    
137
 
(1,338)
 
488
 
(1,338)
Sub-total        
(239)
 
462
 
(53,615)
 
1,418
Elimination of non-cash items included in net income (loss):
 
 
 
 
 
 
 
Depreciation and amortization        
5,385
 
5,404
 
10,611
 
10,733
Funds from operations    
5,146
 
5,866
 
(43,004)
 
12,151
Series C preferred dividends        
—
 
2,621
 
—
 
5,242
Funds from operations available to common stockholders    
$ 5,146
 
$ 8,487
 
$ (43,004)
 
$ 17,393

Portfolio Developments

The partial expiration of certain Medicare rate increases has had an adverse impact on the revenues of the operators of nursing home facilities and has negatively impacted some operators’ ability to satisfy their monthly lease or debt payment to us. In several instances, we hold security deposits that can be applied in the event of lease and loan defaults, subject to applicable limitations under bankruptcy law with respect to operators seeking protection under Chapter 11 of the Bankruptcy Act.

 
     
 
Haven Healthcare

·    On April 1, 2004, we purchased three SNFs, representing 399 beds, for a total investment of $26.0 million. Two of the facilities are located in Vermont and the third is located in Connecticut. The facilities were combined into an existing Master Lease with Haven Healthcare (“Haven”). Rent under the Master Lease was increased by approximately $2.7 million for the first lease year commencing on April 1, 2004, with annual increases thereafter. The term of the Master Lease had been increased to ten years on January 1, 2004 and runs through December 31, 2013, followed by two ten-year renewal options. We received a security deposit equivalent to three months of incremental rent.

Senior Management

·    On May 1, 2004, we purchased two SNFs representing 477 beds, for a total investment of $9.4 million. The purchase price includes funds for capital expenditures, additional bed licenses and transaction costs. Both facilities are located in Texas and were combined into an existing Master Lease with Senior Management. Rent under the Master Lease was increased by approximately $1.0 million for the first lease year commencing May 1, 2004, with annual increases thereafter. The term of the Master Lease has been increased to ten years, and is followed by two ten-year renewal options. During the first lease year, Senior Management will fund a security deposit equivalent to approximately four months of incremental rent.

Sun Healthcare Group, Inc.

·    On March 1, 2004, we re-leased two SNFs formerly leased by Sun located in California and representing 117 beds, to a new operator under a Master Lease, which has a ten-year term. The commencement date of the first re-lease was March 1, 2004 with an initial annual lease rate of approximately $0.12 million. The second facility continues to be operated by Sun as a result of licensing issues. We are currently seeking alternative operators to re-lease or potentially purchase this facility.

·    On March 1, 2004, we entered into an agreement with Sun regarding 51 properties that are leased to various affiliates of Sun. Under the terms of a master lease agreement, Sun will continue to operate and occupy 23 long-term care facilities, five behavioral properties and two hospital properties through December 31, 2013. One property, located in Washington and formerly operated by a Sun affiliate, has already been closed and the lease relating to that property has been terminated. With respect to the remaining 20 facilities, 17 have already been transitioned to new operators and three are in the process of being transferred to new operators.

·    Under our restructuring agreement with Sun, we received the right to convert deferred base rent owed to us, totaling approximately $7.8 million, into 800,000 shares of Sun’s common stock, subject to certain anti-dilution provisions and Sun’s right to pay cash in an amount equal to the value of that stock in lieu of issuing stock to us.

·    On March 30, 2004, we notified Sun of our intention to exercise our right to convert the deferred base rent into fully paid and non-assessable shares of Sun’s common stock. On April 16, 2004, we received a stock certificate for 760,000 restricted shares of Sun’s common stock and cash in the amount of approximately $0.5 million in exchange for the remaining 40,000 shares of Sun’s common stock. On July 23, 2004, Sun registered these shares with the SEC. We are accounting for the remaining 760,000 shares as “available for sale” marketable securities with changes in market value recorded in other comprehensive income.

·    Effective January 1, 2004, we re-leased five SNFs to an existing operator under a new Master Lease, which has a five-year term and an initial annual lease rate of $0.75 million. Four former Sun SNFs, three located in Illinois and one located in Indiana, representing an aggregate of 449 beds, were part of the transaction. The fifth SNF in the transaction, located in Illinois and representing 128 beds, was the last remaining owned and operated facility in our portfolio.

Claremont Healthcare Holdings, Inc.


Tiffany Care Centers, Inc.

·    On April 6, 2004, we received approximately $4.6 million in proceeds on a mortgage loan payoff. We held mortgages on five facilities located in Missouri, representing 319 beds, which produced approximately $0.5 million of annual interest revenue in 2003.

Asset Dispositions in 2004


Other Assets

·    In connection with refinancing our $225 million senior secured credit facility, we sold our $200 million interest rate cap on March 31, 2004. Net proceeds from the sale totaled approximately $3.5 million and resulted in a loss of approximately $6.5 million, which was recorded in the first quarter of 2004.

Closed Facilities



Liquidity and Capital Resources

At June 30, 2004, we had total assets of $752.3 million, stockholders’ equity of $388.8 million and debt of $338.5 million, representing approximately 46.5% of total capitalization. In addition, as of June 30, 2004, we had an aggregate of $350 thousand of scheduled principal payments in 2004.
 
     
 

The following table shows the amounts due in connection with the contractual obligations described below as of June 30, 2004.

 
  
Payments due by period
   
 
  
 
Total
Less than
1 year
 
1-3 years
 
3-5 years
More than
5 years
   
 
  
(In thousands)
Long-term debt (1)
  
$
338,520
  
$
350
  
$
136,050
  
$
700
  
$
201,420
  
Other long-term liabilities
    
937
    
201
    
602
    
134
    
-
  
   
 
 
 
 
 
Total
  
$
339,457
  
$
551
  
$
136,652
  
$
834
  
$
201,420
  
   
 
 
 
 
 

(1)The $338.5 million includes the $100.0 million aggregate principal amount of 6.95% Senior Notes due 2007, $35 million borrowings under the $175 million credit facility borrowing, which matures in March 2008 and $200 million aggregate principal amount of 7.0% Senior Notes due 2014.

Financing Activities and Borrowing Arrangements

Bank Credit Agreements

We have a $175 million revolving senior secured credit facility (“Credit Facility”). At June 30, 2004, $35.0 million was outstanding under the Credit Facility and $4.6 million was utilized for the issuance of letters of credit, leaving availability of $135.4 million. The $35.0 million of outstanding borrowings had a blended interest rate of 4.10% at June 30, 2004.

On April 30, 2004, we exercised our right to increase the revolving commitments under our Credit Facility by an additional $50 million, to $175 million. All other terms of the credit facility, which closed on March 22, 2004, remain the same. Bank of America, N.A. serves as Administrative Agent for the Credit Facility.

We are required to meet certain property level financial covenants and corporate financial covenants, including prescribed leverage, fixed charge coverage, minimum net worth, limitations on additional indebtedness and limitations on dividend payouts on our long-term borrowings. As of June 30, 2004, we were in compliance with all property level and corporate financial covenants.

Series A Preferred Redemption

On April 30, 2004, we redeemed all of the outstanding 2.3 million shares of our Series A preferred stock at a price of $25.57813, comprised of the $25 per share liquidation value and accrued dividend. Under FASB-EITF Issue D-42, ‘‘The Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock,” the repurchase of the Series A preferred stock resulted in a non-cash charge to net income available to common stockholders of approximately $2.3 million. This non-cash charge did not have any effect on our net worth.

Series C Preferred Stock Repurchase

On February 5, 2004, we announced that Explorer Holdings L.P. (“Explorer”), our then largest stockholder, granted us the option to repurchase up to 700,000 of our Series C preferred stock which were convertible into our common shares held by Explorer at a negotiated purchase price of $145.92 per share of Series C preferred stock (or $9.12 per common share on an as converted basis). Explorer further agreed to convert any remaining Series C preferred stock into common stock.


Series D Preferred Stock Offering

On February 10, 2004, we announced the closing of the sale of 4,739,500 shares of our 8.375% Series D cumulative redeemable preferred stock (the “Series D preferred stock”) at a price of $25 per share. The Series D preferred stock is listed on the New York Stock Exchange (“NYSE”) under the symbol “OHI PrD.”

Series C Preferred Stock Redemption and Conversion

We used approximately $102.1 million of the net proceeds from the Series D preferred stock offering to repurchase 700,000 shares of our Series C preferred stock from Explorer. In connection with the closing of the repurchase, Explorer converted its remaining 348,420 Series C preferred stock into approximately 5.6 million shares of our common stock. Following the repurchase and conversion, Explorer held approximately 18.1 million of our common shares.

The combined repurchase and conversion of the Series C preferred stock reduced our preferred dividend requirements, increased our market capitalization and facilitated future financings by simplifying our capital structure. Under FASB-EITF Issue D-42, ‘‘The Effect on the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock,” the repurchase of the Series C preferred stock resulted in a non-cash charge to net income available to common stockholders of approximately $38.7 million.

18.1 Million Secondary and 2.7 Million Primary Offering of Omega Common Stock

On March 8, 2004, we announced the closing of an underwritten public offering of 18.1 million shares of our common stock at $9.85 per share owned by Explorer (the “Secondary Offering”). As a result of the Secondary Offering, Explorer no longer owned any shares of our common stock. We did not receive any proceeds from the sale of the shares sold by Explorer.

In connection with the Secondary Offering, we issued approximately 2.7 million additional shares of our common stock at a price of $9.85 per share, less underwriting discounts (the “Over-allotment Offering”), to cover over-allotments in connection with the Secondary Offering. We received net proceeds of approximately $22.4 million from the Over-allotment Offering.

$200 Million 7% Senior Unsecured Notes Offering and $125 Million Credit Facility

Effective March 22, 2004, we closed (i) a private offering of $200 million aggregate principal amount of 7% Senior Notes due 2014 (the “Initial Notes”) and (ii) the Credit Facility provided by Bank of America, N.A., Deutsche Bank AG, UBS Loan Finance, LLC and GE Healthcare Financial Services.

We used proceeds from the Notes offering to replace and terminate our previous $225 million senior secured credit facility and $50 million acquisition credit facility (the “Prior Credit Facility”), which have been terminated. The remaining proceeds will be used for working capital and general corporate purposes. The Credit Facility will be used for acquisitions and general corporate purposes. In connection with the termination of the Prior Credit Facility, we recorded a charge of approximately $12.6 million, of which $6.3 million consisted of non-cash charges relating to deferred financing costs of the previous credit facilities. The Initial Notes represents our unsecured senior obligations and have been guaranteed by all of our subsidiaries. The Initial Notes were issued in a private placement transaction.

On June 21, 2004, we filed a registration statement on Form S-4, which was amended on July 26, 2003, under the Securities Act of 1933, as amended (the “Securities Act”), with the SEC offering to exchange up to $200 million aggregate principal amount of our 7% Senior Notes due 2014 (the “Exchange Notes”), for all of our outstanding unregistered Initial Notes. The terms of the Exchange Notes are identical to the terms of the Initial Notes, except that the Exchange Notes will be registered under the Securities Act and therefore freely tradable (subject to certain conditions). The Exchange Notes evidence the same indebtedness as the Initial Notes, and will be guaranteed by certain of our present and future domestic restricted subsidiaries with unconditional guarantees of payment that will rank equally with existing and future senior unsecured debt of such subsidiari es and senior to existing and future subordinated debt of such subsidiaries.

$200 Million Interest Rate Cap Sale

In connection with the repayment and termination of our Prior Credit Facility, we sold our $200 million interest rate cap on March 31, 2004. Net proceeds from the sale totaled approximately $3.5 million and resulted in a loss of approximately $6.5 million, which was recorded in the first quarter of 2004.

Dividends

In order to qualify as a REIT, we are required to distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (i) 90% of our "REIT taxable income" (computed without regard to the dividends paid deduction and our net capital gain), and (ii) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income. In addition, if we dispose of any built-in gain asset during a recognition period, we will be required to distribute at least 90% of the built-in gain (after tax), if any, recognized on the disposition of such asset. Such distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our tax return for such year and paid on or before the first regular dividend payment after such declaration . In addition, such distributions are required to be made pro rata, with no preference to any share of stock as compared with other shares of the same class, and with no preference to one class of stock as compared with another class except to the extent that such class is entitled to such a preference. To the extent that we do not distribute all of our net capital gain or do distribute at least 90%, but less than 100% of our "REIT taxable income," as adjusted, we will be subject to tax thereon at regular ordinary and capital gain corporate tax rates. In addition, our Credit Facility has certain financial covenants which limit the distribution of dividends paid during a fiscal quarter to no more than 95% of our immediately prior fiscal quarter’s FFO as defined in the loan agreement governing the Credit Facility (the “Loan Agreement”), unless a greater distribution is required to maintain REIT status. The Loan Agreement, in general, defines FFO as net income (or loss), plus depreciation and amo rtization and shall be adjusted for charges related to (i) restructuring our debt, (ii) redemption of preferred stock, (iii) litigation charges up to $5.0 million, (iv) non-cash charges for accounts and notes receivable up to $5.0 million, and (v) non-cash impairment charges.

On July 20, 2004 our Board of Directors announced a common stock dividend of $0.18 per share. The common stock dividend will be paid August 16, 2004 to common stockholders of record on July 30, 2004. In addition our Board of Directors also declared its regular quarterly dividends for our 8.625% Series B cumulative preferred stock (the “Series B preferred stock”) and our Series D preferred stock to preferred stockholders of record on July 30, 2004. These holders of Series B preferred stock and Series D preferred stock will be paid dividends in the amount of $0.53906 and $0.52344, per preferred share, respectively, on August 16, 2004. The liquidation preference for each of our Series B preferred stock and Series D preferred stock is $25 per share. Regular quarterly preferred dividends represent dividends for the period May 1, 2004 through July 31, 2004 for both the Series B preferred stock and the Series D preferred stock.

On March 29, 2004, our Board of Directors declared regular quarterly dividends for all classes of preferred stock, payable on May 17, 2004 to preferred stockholders of record on April 30, 2004. Holders of record on April 30, 2004 of Series B preferred stock and Series D preferred stock received dividends in the amount of $0.53906 and $0.47109, per preferred share, respectively, on May 17, 2004. The liquidation preference for each of our 8.625% Series B preferred stock and our Series D preferred stock is $25 per share. Regular quarterly preferred dividends represent dividends for the period February 1, 2004 through April 30, 2004 for the Series B preferred stock and February 10, 2004 through April 30, 2004 for the Series D preferred stock.

In March 2004, our Board of Directors authorized the redemption of all outstanding 2.3 million shares of our Series A preferred stock. The Series A preferred stock was redeemed on April 30, 2004 for $25 per share, plus $0.57813 per share in accrued and unpaid dividends through the redemption date, for an aggregate redemption price of $25.57813 per share.

On April 20, 2004, our Board of Directors announced a common stock dividend of $0.18 per share, which is a $0.01 per share, or 5.9%, increase over the previous quarter’s dividend. The common stock dividend was paid May 17, 2004 to common stockholders of record on April 30, 2004. At the date of this filing, we had approximately 46.6 million common shares outstanding.

Liquidity

We believe our liquidity and various sources of available capital, including funds from operations, our existing availability under our Credit Facility and expected proceeds from planned asset sales are adequate to finance operations, meet recurring debt service requirements and fund future investments through the next twelve months.

The primary source of liquidity is our cash flows from operations. Operating cash flows have historically been determined by: (i) the number of facilities we lease or have mortgages on, (ii) rental and mortgage rates, (iii) our debt service obligations, and (iv) general, administrative and legal expenses. The timing, source and amount of cash flows provided by financing activities and used in investing activities are sensitive to the capital markets environment, especially to changes in interest rates. Changes in the capital markets environment may impact the availability of cost-effective capital and affect our plans for acquisition and disposition activity.

We regularly review our liquidity needs, the adequacy of cash flow from operations, and other expected liquidity sources to meet these needs. We believe our principal short-term liquidity needs are to fund:

Cash and cash equivalents totaled $2.7 million as of June 30, 2004, a decrease of $0.4 million as compared to the balance at December 31, 2003. The following is a discussion of changes in cash and cash equivalents due to operating, investing and financing activities, which are presented in our Consolidated Statement of Cash Flows.

Operating Activities – Net cash flow from operating activities generated $24.3 million for the six months ended June 30, 2004 as compared to $31.6 million for the same period in 2003. The $7.3 million decrease is due primarily to a $3.0 million charge associated with professional liability claims (see Note 9 – Litigation) and normal working capital fluctuations during the period.

Investing Activities – Net cash flow from investing activities was an outflow of $30.2 million for the six months ended June 30, 2004 as compared to an inflow of $13.8 million for the same period in 2003. The decrease of $44.0 million was primarily due to: (i) two acquisitions completed in April 2004, and (ii) a decrease of approximately $9.7 million of incremental cash flow from asset sales in 2003 compared to 2004.

Financing Activities – Net cash flow from financing activities generated $5.5 million for the six months ended June 30, 2004 as compared to an outflow of $14.9 million for the same period in 2003. The change in financing cash flow was primarily a result of (i) issuance of $118.5 million of preferred equity, (ii) a public issuance of 2.7 million shares of our common stock at a price of $9.85 per share, (iii) a private offering of the Initial Notes, and (iv) the sale of an interest rate cap. The inflow was partially offset by (i) the redemption of our Series A preferred stock and Series C preferred stock, (ii) repayment of Prior Credit Facility and related termination fees, and (iii) payments of common and preferred dividend payments.


Item 3 – Quantitative and Qualitative Disclosure about Market Risk

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We do not enter into derivatives or other financial instruments for trading or speculative purposes, but we seek to mitigate the effects of fluctuations in interest rates by matching the term of new investments with new long-term fixed rate borrowing to the extent possible.
 
The following disclosures of estimated fair value of financial instruments are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument. The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. Accordingly, the estimates presented below are not necessarily indicative of the amounts we would realize in a current market exchange.

Mortgage notes receivable - The fair value of mortgage notes receivable is estimated by discounting the future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.
 
Borrowings under lines of credit arrangement - The carrying amount approximates fair value because the borrowings are interest rate adjustable.

Senior unsecured notes - The fair value of the senior unsecured notes is estimated by discounting the future cash flows using the current borrowing rate available for the similar debt.

The market value of our long-term fixed rate borrowings and mortgages is subject to interest rate risks. Generally, the market value of fixed rate financial instruments will decrease as interest rates rise and increase as interest rates fall. The estimated fair value of our total long-term borrowings at June 30, 2004 was $287.0 million. A one percent increase in interest rates would result in a decrease in the fair value of long-term borrowings by approximately $11.9 million.

Item 4 – Controls and Procedures

Our principal executive officer and principal financial officer are responsible for establishing and maintaining disclosure controls and procedures as defined in the rules promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2004 and, based on that evaluation, our principal executive officer and principal financial officer have concluded that these controls and procedures were effective as of June 30, 2004. No changes in our internal control over financial reporting were identified as having occurred in the fiscal quarter ending June 30, 2004 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Disclosure controls and procedures are the controls and other procedures designed to ensure that information that we are required to disclose in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods required. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

See Note 9 – Litigation to the Consolidated Financial Statements in PART I, Item 1 hereto, which is hereby incorporated by reference in response to this item.

Item 2 – Changes in Securities, Use of Proceeds and Issuer Purchase of Equity Securities

The following table provides information about purchases we made during the fiscal quarter ended June 30, 2004 of securities that are registered by us pursuant to Section 12 of the Exchange Act.

ISSUER PURCHASES OF EQUITY SECURITIES
 
 
 
 
 
Period
 
 
(a)
Total Number of Shares Purchased (1)
 
 
 
(b)
Average Price Paid per Share (2)
(c)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Program
(d)
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
Month #1
(April 1, 2004 through April 30, 2004)
 
 
2,300,000
 
 
$25.57813
 
 
2,300,000
 
 
-0-
Month #2
(May 1, 2004 through May 31, 2004)
 
 
--
 
 
--
 
 
--
 
 
--
Month #3
(June 1, 2004 through June 30, 2004)
 
 
--
 
 
--
 
 
--
 
 
--
Total
2,300,000
$25.57813
2,300,000
-0-

____________________
(1)   On April 30, 2004, we fully redeemed our 9.25% Series A cumulative preferred stock (the “Series A Stock”). We redeemed the 2,300,000 shares of Series A Stock at a price of $25.57813, comprised of $25 liquidation value and accrued dividend, pursuant to the terms and conditions of the Series A Stock.
(2)   Our Board of Directors approved the repurchase of 2,300,000 shares of the Series A Stock pursuant to the terms and conditions of the Series A Stock.

Item 3 – Defaults upon Senior Securities

None this period.

 
     
 
Item 4 – Submission of Matters to a Vote of Security Holders

Our annual meeting of stockholders (the “Annual Meeting”) was held on June 3, 2004. Of the total number of common shares outstanding on April 26, 2004, a total of 46,327,948 were represented in person or by proxy at the Annual Meeting. Results of votes with respect to proposals submitted at the Annual Meeting are set forth below.

(a)   To elect two nominees to serve as directors and to hold office until the next annual meeting of stockholders or until their successors have been elected and qualified. Our stockholders voted to elect both nominees to serve as directors. Votes recorded, by nominee, were as follows:

Nominee
 
For
 
Against/Withheld
Edward Lowenthal
 
42,845,084
 
1,516,846
Stephen D. Plavin
 
42,850,435
 
1,511,495


(b)   To consider and vote upon a proposal to amend our Articles of Incorporation to increase the number of authorized shares of preferred stock from 10,000,000 to 20,000,000 shares. Our stockholders voted to approve this proposal with the following results:

For
 
Against
 
Abstain
 
Broker Non-Votes
24,188,007
 
8,179,651
 
342,669
 
11,651,603


(c)   To approve the Omega Healthcare Investors, Inc. 2004 Stock Incentive Plan. Our stockholders voted to approve this proposal with the following results:

For
 
Against
 
Abstain
 
Broker Non-Votes
27,212,070
 
5,106,336
 
391,921
 
11,651,603

 
     
 
Item 6 – Exhibits and Reports on Form 8-K

(a)   Exhibits

Exhibit No.
 
Description
4.1
 
First Supplemental Indenture, dated as of July 20, 2004, by and among the Company and the subsidiary guarantors named therein, OHI Asset II (TX), LLC and U.S. Bank National Association (incorporated by reference to Exhibit 4.8 to the Company’s registration statement on Form S-4, filed with the Securities and Exchange Commission on July 26, 2004, File No. 333-116690).
10.1
 
 First Amendment to Credit Agreement and Assignment Agreement, dated as of June 18, 2004, is entered into by and among OHI Asset, LLC, OHI Asset (ID), LLC, OHI Asset (LA), LLC, OHI Asset (TX), LLC, OHI Asset (CA), LLC, Delta Investors I, LLC, Delta Investors II, LLC, the Lenders named therein, and Bank of America, N.A.
31.1
 
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2
 
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32.1
 
Section 1350 Certification of the Chief Executive Officer.
32.2
 
Section 1350 Certification of the Chief Financial Officer.


(b)    Reports on Form 8-K

(1)   On May 24, 2004, the Company filed a Current Report on Form 8-K, pursuant to Item 5 thereof, providing updated information relating to the Company’s outstanding common stock and options as of April 30, 2004.

(2)   On April 27, 2004, the Company furnished a Current Report on Form 8-K, pursuant to Item 12 thereof, announcing its financial results for the quarter ended March 31, 2004. *
____________________
*   This report contains information furnished to the Commission under Item 12 of Form 8-K, which, pursuant to General Instructions B(2) and (6) of Form 8-K, is not deemed to be “filed” for purposes of Section 18 of the Exchange Act and the Registrant is not subject to the liabilities imposed by that section.


 
     
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OMEGA HEALTHCARE INVESTORS, INC.
Registrant


Date:   August 4, 2004   By:   /S/ C. TAYLOR PICKETT
              C. Taylor Pickett
              Chief Executive Officer

Date:   August 4, 2004   By:   /S/ ROBERT O. STEPHENSON
              Robert O. Stephenson
              Chief Financial Officer